1-2 of 2
Katherine Sheldon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunological Correlates of Treatment with the CTLA-4 Inhibitor Ipilimumab in Patients with Refractory Myelodysplastic Syndromes (MDS)

Tara M. Robinson, MD PhD, Hanna Knaus, MD, B Douglas Smith, MD, Andrea M.H. Towlerton, BS, Edus H. Warren, III, MDPhD, Joshua F Zeidner, MD, Amanda Blackford, Amy S. Duffield, MD PhD, David Rizzieri, MD, Mark G. Frattini, MD PhD, Moshe Levy, MD, Mark A. Schroeder, MD, Anna Ferguson, BSN, RN, Katherine Sheldon, Amy E. DeZern, MD, Ivana Gojo, MD, Steven D. Gore, MD, Howard Streicher, MD, Leo Luznik, MD, Amer M. Zeidan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1699.
https://doi.org/10.1182/blood.V130.Suppl_1.1699.1699
Published: 2017
Journal Articles

Stabilization of Myelodysplastic Syndromes (MDS) Following Hypomethylating Agent (HMAs) Failure Using the Immune Checkpoint Inhibitor Ipilimumab: A Phase I Trial

Amer M. Zeidan, MBBS, MHS, Joshua F. Zeidner, MD, Amy Duffield, MD, Hanna A. Knaus, MD, Anna Ferguson, BSN, RN, Katherine Sheldon, Amy E. DeZern, MD MHS, Ivana Gojo, MD, Steven D. Gore, MD, Howard Streicher, MD, Leo Luznik, B. Douglas Smith
Journal: Blood
Blood (2015) 126 (23): 1666.
https://doi.org/10.1182/blood.V126.23.1666.1666
Published: 2015